Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR)

Abstract Background Perioperative chemotherapy and surgery are a standard of care for patients with resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma. However, the prognosis remains poor for this population. The FLOT (fluorouracil, leucovorin, oxaliplatin, and docetaxel) regimen i...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Mélanie Dos Santos, Justine Lequesne, Alexandra Leconte, Stéphane Corbinais, Aurélie Parzy, Jean-Marc Guilloit, Sharmini Varatharajah, Pierre-Emmanuel Brachet, Marine Dorbeau, Dominique Vaur, Louis-Bastien Weiswald, Laurent Poulain, Corentin Le Gallic, Marie Castera-Tellier, Marie-Pierre Galais, Bénédicte Clarisse
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2022-05-01
Serie:	BMC Cancer
Soggetti:	Gastric cancer Gastroesophageal junction cancer Neoadjuvant treatment Immunotherapy Spartalizumab
Accesso online:	https://doi.org/10.1186/s12885-022-09623-z
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!